PAYS 最新10-Q变化

相对上期新增的文字 · 来源:10-Q · 2026-08-06

• Comparison of the Six Months Ended June 30, 2026 to the Six Months Ended June 30, 2025

• The following table summarizes our condensed consolidated financial results for the six months ended June 30, 2026 in comparison to the six months ended June 30, 2025:

• The increase in total revenues of $18,613,993 for the six months ended June 30, 2026 compared to the same period in the prior year consisted primarily of a $4,635,347 increase in plasma revenue, a $13,956,026 increase in pharma revenue and a $22,620 increase in other revenue. The increase in plasma …

• Cost of revenues for the six months ended June 30, 2026 increased $5,944,018 compared to the same period in the prior year. Cost of revenues is comprised of transaction processing fees, data connectivity and data center expenses, network fees, bank fees, card production and postage costs, call cente…

• Gross profit for the six months ended June 30, 2026 increased $12,669,975 compared to the same period in the prior year resulting primarily from the launch of an additional 51 net pharma patient affordability programs during the prior twelve-month period, and a corresponding increase in setup fees, …

相对上期删除的文字 · 来源:10-Q · 2026-05-13

• Management reviews a number of metrics to help us monitor the performance of and identify trends affecting our business. We believe the following measures are the primary indicators of our quarterly and annual revenues:

• Gross Dollar Volume Loaded on Cards: Represents the total dollar volume of funds loaded to all our prepaid card programs. Our gross dollar volume loaded on cards was $514 million and $407 million for the three months ended March 31, 2026 and 2025, respectively. We use this metric to analyze the tota…

• Conversion Rates on Gross Dollar Volume Loaded on Cards: Represents revenues, gross profit or net income conversion rates of gross dollar volume loaded on cards which are calculated by taking our total revenues, gross profit or net income, respectively, as a numerator and dividing by the gross dolla…

• We used net cash in investing activities during the three months ended March 31, 2026 and 2025 of $2,075,341 and $4,443,855, respectively. For the three months ended March 31, 2026, cash was used for investing activities primarily attributable to an increase in licenses, fixed assets and capitalizat…